1. Abrams P, Tammela TL, Hellström P, Marberger M, Djavan BR, Lunglmayr G, Panos P, Labal KU (1998) European pressure-flow investigation of tamsulosin in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) – ESPRIT study. J Urol 159:256
2. Akiyama K, Hora M, Tatemichi S, Masuda N, Nakamura S, Yamagishi R, Kitazawa M (1999) KMD-3213, a uroselective and long-acting α1a-adrenoceptor antagonist, tested in a novel rat model. J Pharmacol Exp Ther 291:81–91
3. Andersson KE (2002) Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists. World J Urol 19:390–396
4. Andersson KE, Gratzke C (2007) Pharmacology of α1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 4:368–378
5. Andersson KE, Larsson B, Sjogren C (1984) Characterization of the α-adrenoceptors in the female rabbit urethra. Br J Pharmacol 81:293–300